Listeria-based vaccination against the pericyte antigen RGS5 elicits anti-vascular effects and colon cancer protection

Document Details

Document Type
Pub Defense Publication
Publication Date
Sep 28, 2023
Source ID
10.1080/2162402x.2023.2260620

Entities

People

  • Amanda L. McCormick
  • Devin B. Lowe
  • Duke Appiah
  • Elizabeth A. Daugherity
  • Izuchukwu F. Okpalanwaka
  • Laurence M. Wood
  • Mariam Oladejo
  • Savanna L. Smith
  • Trevor S. Anderson

Organizations

  • Cancer Prevention and Research Institute of Texas
  • National Institutes of Health
  • Texas Tech University Health Sciences Center
  • United States Department of Defense

Tags

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech